• Bioharvest Sciences Inc 8MV0.MU reported a quarterly adjusted loss of 24 cents​​ per share for the quarter ended June 30. The mean expectation of four analysts for the quarter was for a loss of 16 cents per share. Wall Street expected results to range from -24 cents to -11 cents per share.

• Revenue was $8.52 million​; analysts expected $8.51 million.

• Bioharvest Sciences Inc's reported EPS for the quarter was a loss of 24 cents​.

• The company reported a quarterly loss of $4.08 million.

• Bioharvest Sciences Inc shares had risen by 31.1% this quarter and gained 42.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 95.8% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• Wall Street's median 12-month price target for Bioharvest Sciences Inc is $14.50, about 39.2% above its last closing price of $8.82

This summary was machine generated from LSEG data August 12 at 05:44 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)